Document is current
Any future updates will be listed below
-
Authors
Bowers, Sarah M. https://orcid.org/0000-0002-5237-2653
Gibson, Kristen M.
Cabral, David A.
Brown, Kelly L.
-
Funding
Funding for this research was provided by:
Canadian Institute of Health Research (TR2-119188)
Centre for Blood Research, University of British Columbia (Summer Studentship Award)
Faculty of Medicine, University of British Columbia (5728)
University of British Columbia (6456)
The Arthritis Society (Ross Petty Arthritis Society Chair)
Michael Smith Foundation for Health Research (Cassie and Friends Society Scholar Award)
- License Information
-
More Information
Article History
Received: 27 December 2019
Accepted: 30 June 2020
First Online: 10 July 2020
Ethics approval and consent to participate
: Healthy adults and children diagnosed with Deficiency of adenosine deaminase 2 (DADA2) were enrolled in the Pediatric Vasculitis Initiative (PedVas) as described previously [, ]. The study protocol was approved by the Children’s and Women’s Research Ethics Board of the University of British Columbia (H12–00894) and the respective ethical committees or IRBs at participating PedVas study sites. Healthy children and young adults were enrolled to the British Columbia (BC) Children’s Hospital BioBank; study protocol approved by the Children’s and Women’s Research Ethics Board of the University of British Columbia (H13–03111).
: Not applicable.
: None declared.
